Evidence map›Paper›PMID 42324448›Full record

ArticleBMC microbiology2026

Development of an ex vivo skin model for quantitative recovery and preservation of donor-specific human microbiota.

Angela Patatian, Chrisse Ngari, Caroline Durand, Delhia Romain, Christelle Guéré, Katell Vie, Valérie Poulet, Giuseppe Percoco, Damien Seyer

Abstract read
In one paragraph

Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Angela Patatian *Eurofins BIO-EC, 1 chemin de Saulxier, Longjumeau, 91160, France.
Chrisse Ngari *Laboratoires Clarins, 5 Rue Ampère, Pontoise, 95300, France. chrisse.ngari@clarins.com.
Caroline DurandEurofins BIO-EC, 1 chemin de Saulxier, Longjumeau, 91160, France.
Delhia RomainEurofins BIO-EC, 1 chemin de Saulxier, Longjumeau, 91160, France.
Christelle GuéréLaboratoires Clarins, 5 Rue Ampère, Pontoise, 95300, France.
Katell VieLaboratoires Clarins, 5 Rue Ampère, Pontoise, 95300, France.
Valérie PouletLaboratoires Clarins, 5 Rue Ampère, Pontoise, 95300, France.
Giuseppe Percoco *Eurofins BIO-EC, 1 chemin de Saulxier, Longjumeau, 91160, France.
Damien Seyer *ERRMECe laboratory, Biomaterials for Health Group, CY Cergy Paris Université, Maison Internationale de la Recherche, 1 rue Descartes, Neuville sur Oise, Cergy , 95031, France. damien.seyer@cyu.fr.ORCID 0000-0001-7510-0573

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThrough multi-omics approaches, our understanding of skin microbiota has substantially advanced. However, the development of reliable and physiologically relevant experimental models would greatly accelerate progress in microbiome-targeted science. Most investigations of skin microbiota rely on in vitro 2D models or reconstructed epidermis colonized with a limited number of strains, which do not reflect the complexity and the spatial microbial organization observed on in vivo skin. To overcome these limitations, we developed a model based on perfused human skin explants (Perfex model), that enables the transfer of complex bacterial communities from human volunteers onto ex vivo skin.

resultsAfter quantitative validation of recovered microbial DNA by qPCR from volunteers (V1-V2-V3) and corresponding inoculated explants (MV1-MV3), 16S rRNA gene sequencing was performed to assess whether microbiota transfer influenced community structure and diversity. No statistically significant differences in alpha-diversity were observed between original and transferred microbiota at the genus level, suggesting that the transfer procedure did not substantially alter overall community diversity. Clustering analysis revealed distinct grouping of samples according to donor origin, indicating that donor-specific microbial signatures were largely maintained on the explants after 48 hours. Control samples formed separate clusters, suggesting minimal background signal and supporting the absence of cross-contamination. These observations indicate that the model enables clear discrimination between the endogenous microbiota of the explants and the transferred microbiota, supporting the integrity of the experimental conditions. Beta-diversity analysis based on Bray-Curtis supported these findings. Across samples, microbial communities were characterized by the recurrent presence of common skin-associated genera such as Cutibacterium, Staphylococcus, and Corynebacterium. Histological analyses demonstrated preserved tissue architecture, while immunostaining revealed modulation of selected innate immune markers consistent with a localized skin response to microbial transfer.

conclusionsThe Perfex model enables transfer of donor-specific skin microbiota to ex vivo human skin while preserving tissue integrity over short-term culture. This model provides a human-relevant platform for studying host-microbiota interactions under controlled conditions and for preclinical evaluation of microbiome-targeted therapies and dermo-cosmetic treatments.

Indexed as

BacteriaMicrobiotaSkinSkin MicrobiomeDNA, BacterialHumansRNA, Ribosomal, 16SSequence Analysis, DNADNA, BacterialRNA, Ribosomal, 16S16S rRNA gene sequencingBiological modelsEx vivo human skinHost–microbe interactionsMicrobial diversityMicrobiota transferSkin microbiota

Identifiers

PMID42324448
PMCPMC13536799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.